The activation of Erk1/2, JNK has been reported in prostate cancer and colon cancer [42, 43], and the activation of ERK1/2 and Akt and inactivation of JNK were found in lung cancer [44]. This evidence concerns the gene MAPK8 and prostate carcinoma.